| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 1,845 | 779 | 1,060 | 109 | | Selling General and Administrative | 770 | 860 | 850 | 704 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,637) | (1,639) | (1,910) | (813) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 20 | (78) | 66 | (20) | | Earnings Before Interest And Taxes | (1,617) | (1,717) | (1,844) | (833) | | Interest Expense |
-
| (150) | 150 |
-
| | Income Before Tax | (1,617) | (1,567) | (1,994) | (833) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,617) | (1,567) | (1,994) | (833) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,617) | (1,567) | (1,994) | (833) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,617) | ($1,567) | ($1,994) | ($833) |
|
0.01% Nasdaq 
0.20%
Income Statement
